Invo BioScience (INVO)
(Delayed Data from NSDQ)
$0.69 USD
+0.01 (0.92%)
Updated Sep 19, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Invo BioScience Inc. [INVO]
Reports for Purchase
Showing records 1 - 18 ( 18 total )
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
4Q20 Recap - Momentum Building for INVO-Owned Centers
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
We launch coverage with a Buy rating and a $5.75/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
|